How to Buy Cartesian Therapeutics Stock
Cartesian Therapeutics Inc
Selecta Biosciences, Inc. , a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases.
Cartesian Therapeutics stock last closed at $12.00, up 0.84% from the previous day, and has decreased 45.63% in one year. It has overperformed other stocks in the Biotechnology industry by 0.31 percentage points. Cartesian Therapeutics stock is currently +35.59% from its 52-week low of $8.85, and -71.34% from its 52-week high of $41.87.
At the moment, there are 25.91M shares of RNAC outstanding. The market capitalization of RNAC is $310.89M. In the last 24 hours, 43,656 RNAC shares were traded.
How to Buy Cartesian Therapeutics Stock
Not sure how to invest in Cartesian Therapeutics stock? Here's how.
- Figure out where to buy Cartesian Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Cartesian Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Select your payment method and add your info.
- Research Cartesian Therapeutics stock: The Cartesian Therapeutics ticker symbol is RNAC. Is Cartesian Therapeutics stock a good investment? Should you buy shares of RNAC? How do RNAC's underlying business fundamentals look? Do top analysts think Cartesian Therapeutics is a good buy? Why has RNAC's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if RNAC is a good stock to buy).
- Place your RNAC buy order: Decide if you will purchase RNAC shares at the current market price or use a limit order to buy RNAC shares at a given price.
- Get the latest news on your RNAC investment: Create a watchlist to watch your position in Cartesian Therapeutics stock.
Step 1: Figure out where to buy Cartesian Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy RNAC stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal information so you are able to invest in RNAC today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new brokerage account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have opened your account on the best stock app, you need to deposit funds:
Check out the walkthrough below to see the process of transferring money into your investment account.
Step 4: Research Cartesian Therapeutics stock
After you have figured out the best place to buy Cartesian Therapeutics stock, it's absolutely critical to research their stock prior to investing, so you truly understand the risk as well as the opportunity.
Cartesian Therapeutics Numbers
RNAC Fundamentals
WallStreetZen was created to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on RNAC's stock page.
Is RNAC stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge RNAC's true value.
You can do additional valuation analysis on RNAC's stock here.
A look at RNAC Cashflows and Balance Sheet
Pros:
- There are more short-term assets than short-term liabilities on the RNAC balance sheet.
- RNAC has $212.61M in cash and short term investments. This is sufficient to cover its annual cash burn of $32.42M.
- RNAC has cash burn of 32416000. It has sufficient cash and short-term investments to cover this for at least one year.
Cons:
- RNAC debt to equity ratio of -64.96 is negative.
- RNAC profit margin has gone up by 6.46 percentage points in the past year, but the company is still unprofitable.
- Total RNAC debt is still negative.
- There are more long-term liabilities than short-term assets on the RNAC balance sheet.
Is Cartesian Therapeutics stock a Buy, Hold, or Sell, according to analysts?
Out of 3 sell side analysts who track RNAC, the consensus analyst rating on RNAC is a Strong Buy
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Cartesian Therapeutics stock forecast page.
RNAC Technical Indicators
RNAC Performance Numbers
Last year, RNAC revenue was $38.91M. Over the last five year, RNAC's revenue has grown by 42.27% per year. This was slower than the Biotechnology industry average of 45.66%.
Find out more about RNAC's earnings and revenue performance here.
Who is buying/selling RNAC?
In the last year, insiders at RNAC have bought more shares than they have sold.
Emily English, Chief Operations Officer of RNAC, was the latest RNAC insider to buy. They bought $24,750.00 worth of RNAC stock on Apr 15, 2025.
Dig into more about who owns RNAC shares here.
Can I get consistent income from RNAC stock?
No, Cartesian Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about RNAC
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your RNAC buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific price, place a limit order.
Hit the Open button and your broker will place the order.
If you require more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your RNAC investment
Now that you own some RNAC shares, you'll want to keep up with your investment.
Put RNAC on a watchlist to see the latest developments about your RNAC stock.
RNAC Feed
How to Buy Stock in Cartesian Therapeutics
To summarize, here are the 6 steps you need to take to buy Cartesian Therapeutics stock right now:
- Figure out where to buy Cartesian Therapeutics stock
- Create a brokerage account
- Deposit money your investment account
- Research Cartesian Therapeutics stock
- Place your RNAC buy order
- Get the latest news on your RNAC investment
If you need a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Cartesian Therapeutics, hit the button below to create your watchlist.
Other "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.